909543-30-2

Basic information

• Product Name: (2S)-2-({6-chloro-3-[6-(4-chlorophenoxy)-2-propylpyridin-3-yl]-1,2-benzisoxazol-5-yl}oxy)propanoic acid
• Synonyms: (2S)-2-({6-chloro-3-[6-(4-chlorophenoxy)-2-propylpyridin-3-yl]-1,2-benzisoxazol-5-yl}oxy)propanoic acid
• CAS NO: 909543-30-2
• Molecular Weight: 487.339
• Mol File: 909543-30-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (2S)-2-({6-chloro-3-[6-(4-chlorophenoxy)-2-propylpyridin-3-yl]-1,2-benzisoxazol-5-yl}oxy)propanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-2-({6-chloro-3-[6-(4-chlorophenoxy)-2-propylpyridin-3-yl]-1,2-benzisoxazol-5-yl}oxy)propanoic acid(909543-30-2)
• EPA Substance Registry System: (2S)-2-({6-chloro-3-[6-(4-chlorophenoxy)-2-propylpyridin-3-yl]-1,2-benzisoxazol-5-yl}oxy)propanoic acid(909543-30-2)

Safety Data

• Hazardous Substances Data: 909543-30-2(Hazardous Substances Data)

Upstream product

• 948897-70-9 C₇H₈O₃S*C₂₁H₁₆Cl₂N₂O₃ 
• 65515-28-8 methyl 2,6-dichloronicotinate 
• 2100-42-7 2-chloro-1,4-dimethoxybenzene 
• 948897-63-0 C₂₁H₁₇Cl₂NO₄ 
• 948897-62-9 C₂₃H₂₁Cl₂NO₄ 
• 925207-28-9 methyl 6-(4-chloro-phenoxy)-2-propylnicotinate 
• 948897-61-8 C₁₅H₁₄ClNO₃ 
• 38496-18-3 2,6-dichloropyridine-3-carboxylic acid 
• 906794-87-4 methyl 2-chloro-6-(4-chlorophenoxy)nicotinate 

Downstream Products

• 948897-66-3 (2S)-2-({6-chloro-3-[6-(4-chlorophenoxy)-2-propylpyridin-3-yl]-1,2-benzisoxazol-5-yl}oxy)propanoic acid tosylate salt 

Relevant articles and documents

NOVEL CRYSTALLINE SALT FORM OF AN ANTIDIABETIC COMPOUND

A novel crystalline anhydrous toluenesulfonic acid salt form of a selective PPAR gamma partial agonist which has a fused bicyclic aromatic group attached to an oxypropanoic acid moiety is stable and non-hygroscopic. The crystalline salt form is useful for

FUSED AROMATIC COMPOUNDS HAVING ANTI-DIABETIC ACTIVITY

Fused aromatic compounds of Formula (I) are PPAR gamma agonists or partial agonists and are useful in the treatment or control of type II diabetes, including hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obes